Jenny A. Greig

2.1k total citations · 1 hit paper
37 papers, 1.6k citations indexed

About

Jenny A. Greig is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Jenny A. Greig has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 22 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Jenny A. Greig's work include Virus-based gene therapy research (26 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Jenny A. Greig is often cited by papers focused on Virus-based gene therapy research (26 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Jenny A. Greig collaborates with scholars based in United States, United Kingdom and Japan. Jenny A. Greig's co-authors include James M. Wilson, Andrew H. Baker, Laura Denby, Alan L. Parker, John H. McVey, Suzanne M. K. Buckley, Simon N. Waddington, Stuart A. Nicklin, Peter Bell and Nico van Rooijen and has published in prestigious journals such as Cell, Blood and Nature Biotechnology.

In The Last Decade

Jenny A. Greig

37 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer

2008 500 citations Simon N. Waddington, John H. McVey et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenny A. Greig United States	18	1.0k	889	363	229	224	37	1.6k
Christopher W. Peterson United States	21	795 0.8×	358 0.4×	287 0.8×	144 0.6×	112 0.5×	49	1.4k
Stephanie Laufs Germany	22	824 0.8×	574 0.6×	394 1.1×	89 0.4×	62 0.3×	59	1.3k
Kathrin M. Bernt United States	23	1.8k 1.8×	539 0.6×	453 1.2×	147 0.6×	97 0.4×	58	2.4k
Kirk Chu United States	14	1.1k 1.1×	612 0.7×	219 0.6×	362 1.6×	90 0.4×	18	1.5k
Yunyu Spence United States	12	766 0.8×	827 0.9×	306 0.8×	66 0.3×	126 0.6×	16	1.1k
AW Nienhuis United States	28	2.0k 1.9×	1.0k 1.1×	345 1.0×	100 0.4×	136 0.6×	53	3.0k
Ben Weisburd United States	8	676 0.7×	295 0.3×	304 0.8×	182 0.8×	59 0.3×	16	1.4k
Delila Serra United States	21	753 0.7×	676 0.8×	354 1.0×	170 0.7×	205 0.9×	30	1.5k
Klaudia Kuranda France	16	1.1k 1.0×	743 0.8×	504 1.4×	45 0.2×	113 0.5×	24	1.7k
Ravi Misra United States	19	1.1k 1.1×	210 0.2×	139 0.4×	184 0.8×	55 0.2×	37	1.6k

Countries citing papers authored by Jenny A. Greig

Since Specialization

Citations

This map shows the geographic impact of Jenny A. Greig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny A. Greig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny A. Greig more than expected).

Fields of papers citing papers by Jenny A. Greig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny A. Greig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny A. Greig. The network helps show where Jenny A. Greig may publish in the future.

Co-authorship network of co-authors of Jenny A. Greig

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny A. Greig. A scholar is included among the top collaborators of Jenny A. Greig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny A. Greig. Jenny A. Greig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aras, Shweta, Ashleigh Morgan, Nesteene J. Param, et al.. (2024). Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis. Cancer Gene Therapy. 31(5). 766–777. 1 indexed citations

Greig, Jenny A., Camilo Breton, Jason Lamontagne, et al.. (2023). Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration. Nature Biotechnology. 42(8). 1232–1242. 73 indexed citations

Breton, Camilo, et al.. (2023). Prevalent and Disseminated Recombinant and Wild-Type Adeno-Associated Virus Integration in Macaques and Humans. Human Gene Therapy. 34(21-22). 1081–1094. 17 indexed citations

Greig, Jenny A., Camilo Breton, Yanqing Zhu, et al.. (2022). Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases. Human Gene Therapy. 33(21-22). 1174–1186. 5 indexed citations

Horiuchi, Makoto, Christian Hinderer, Jenny A. Greig, et al.. (2022). Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors. Molecular Therapy — Methods & Clinical Development. 27. 272–280. 8 indexed citations

Sims, Joshua J., Jenny A. Greig, Kristofer T. Michalson, et al.. (2021). Intranasal gene therapy to prevent infection by SARS-CoV-2 variants. PLoS Pathogens. 17(7). e1009544–e1009544. 28 indexed citations

Greig, Jenny A., Tamara Goode, Elizabeth L. Buza, et al.. (2021). Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A. Human Gene Therapy. 33(7-8). 421–431. 2 indexed citations

Greig, Jenny A., Christine Draper, Yanqing Zhu, et al.. (2019). A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease. PubMed. 30(1). 29–39. 19 indexed citations

Greig, Jenny A., Maria P. Limberis, Peter Bell, et al.. (2017). Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR ^+/− Rhesus Macaques. Europe PMC (PubMed Central). 28(1). 39–50. 44 indexed citations

10.

Greig, Jenny A., Maria P. Limberis, Peter Bell, et al.. (2017). Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia. PubMed. 28(1). 28–38. 34 indexed citations

11.

Greig, Jenny A., Roberto Calcedo, Rebecca Grant, et al.. (2016). Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques. Vaccine. 34(50). 6323–6329. 38 indexed citations

12.

Greig, Jenny A., Erin Bote, Lisa Kattenhorn, et al.. (2016). Impact of intravenous infusion time on AAV8 vector pharmacokinetics, safety, and liver transduction in cynomolgus macaques. Molecular Therapy — Methods & Clinical Development. 3. 16079–16079. 16 indexed citations

13.

Greig, Jenny A., Hui Peng, Jason F. Ohlstein, et al.. (2014). Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression. PLoS ONE. 9(11). e112268–e112268. 46 indexed citations

14.

Wang, Lili, J.P. Louboutin, Peter Bell, et al.. (2011). Muscle‐directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors. Journal of Thrombosis and Haemostasis. 9(10). 2009–2019. 18 indexed citations

15.

Caruso, Paola, Margaret R. MacLean, Raya Khanin, et al.. (2010). Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline. Arteriosclerosis Thrombosis and Vascular Biology. 30(4). 716–723. 287 indexed citations

16.

Alba, Raúl, Angela C. Bradshaw, Lynda Coughlan, et al.. (2010). Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Blood. 116(15). 2656–2664. 90 indexed citations

17.

Greig, Jenny A., Suzanne M. K. Buckley, Simon N. Waddington, et al.. (2009). Influence of Coagulation Factor X on In Vitro and In Vivo Gene Delivery by Adenovirus (Ad) 5, Ad35, and Chimeric Ad5/Ad35 Vectors. Molecular Therapy. 17(10). 1683–1691. 33 indexed citations

18.

Waddington, Simon N., John H. McVey, David Bhella, et al.. (2008). A critical role for the adenovirus serotype 5 hexon in liver gene transfer. Human Gene Therapy. 1 indexed citations

19.

Waddington, Simon N., John H. McVey, David Bhella, et al.. (2008). Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer. Cell. 132(3). 397–409. 500 indexed citations breakdown →

20.

Flavahan, Nicholas A., et al.. (1985). Attempts to uncover subtypes of α-adrenoceptors and associated mechanisms by using sequential administration of blocking drugs. Clinical Science. 68(s10). 25s–30s. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact